Your browser doesn't support javascript.
loading
TBC1D24 emerges as an important contributor to progressive postlingual dominant hearing loss.
Ozieblo, Dominika; Leja, Marcin L; Lazniewski, Michal; Sarosiak, Anna; Tacikowska, Grazyna; Kochanek, Krzysztof; Plewczynski, Dariusz; Skarzynski, Henryk; Oldak, Monika.
Afiliação
  • Ozieblo D; Department of Genetics, Institute of Physiology and Pathology of Hearing, M. Mochnackiego 10, 02-042, Warsaw, Poland.
  • Leja ML; Postgraduate School of Molecular Medicine, Medical University of Warsaw, Warsaw, Poland.
  • Lazniewski M; Department of Genetics, Institute of Physiology and Pathology of Hearing, M. Mochnackiego 10, 02-042, Warsaw, Poland.
  • Sarosiak A; Postgraduate School of Molecular Medicine, Medical University of Warsaw, Warsaw, Poland.
  • Tacikowska G; Laboratory of Functional and Structural Genomics, Centre of New Technologies, University of Warsaw, Warsaw, Poland.
  • Kochanek K; Centre for Advanced Materials and Technologies, Warsaw University of Technology, Warsaw, Poland.
  • Plewczynski D; Department of Genetics, Institute of Physiology and Pathology of Hearing, M. Mochnackiego 10, 02-042, Warsaw, Poland.
  • Skarzynski H; Postgraduate School of Molecular Medicine, Medical University of Warsaw, Warsaw, Poland.
  • Oldak M; Department of Otoneurology, Institute of Physiology and Pathology of Hearing, Warsaw/Kajetany, Poland.
Sci Rep ; 11(1): 10300, 2021 05 13.
Article em En | MEDLINE | ID: mdl-33986365
ABSTRACT
Several TBC1D24 variants are causally involved in the development of profound, prelingual hearing loss (HL) and different epilepsy syndromes inherited in an autosomal recessive manner. Only two TBC1D24 pathogenic variants have been linked with postlingual progressive autosomal dominant HL (ADHL). To determine the role of TBC1D24 in the development of ADHL and to characterize the TBC1D24-related ADHL, clinical exome sequencing or targeted multigene (n = 237) panel were performed for probands (n = 102) from multigenerational ADHL families. In four families, TBC1D24-related HL was found based on the identification of three novel, likely pathogenic (c.553G>A, p.Asp185Asn; c.1460A>T, p. His487Leu or c.1461C>G, p.His487Gln) and one known (c.533C>T, p.Ser178Leu) TBC1D24 variant. Functional consequences of these variants were characterized by analyzing the proposed homology models of the human TBC1D24 protein. Variants not only in the TBC (p.Ser178Leu, p.Asp185Asn) but also in the TLDc domain (p.His487Gln, p.His487Leu) are involved in ADHL development, the latter two mutations probably affecting interactions between the domains. Clinically, progressive HL involving mainly mid and high frequencies was observed in the patients (n = 29). The progression of HL was calculated by constructing age-related typical audiograms. TBC1D24-related ADHL originates from the cochlear component of the auditory system, becomes apparent usually in the second decade of life and accounts for approximately 4% of ADHL cases. Given the high genetic heterogeneity of ADHL, TBC1D24 emerges as an important contributor to this type of HL.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas Ativadoras de GTPase / Genes Dominantes / Perda Auditiva / Desenvolvimento da Linguagem Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas Ativadoras de GTPase / Genes Dominantes / Perda Auditiva / Desenvolvimento da Linguagem Idioma: En Ano de publicação: 2021 Tipo de documento: Article